Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neuro-Oncology
•
Neurology
•
Neuro-critical care
•
Child Neurology
How do different inflammatory markers like CRP and ferritin contribute differently, if at all, to the monitoring of CART neurotoxicity?
Related Questions
Would you recommend a specific workup or change in management for patients with severe, persistent deficits from methotrexate leukoencephalopathy?
How do you use amantadine and assess its efficacy for comatose pediatric patients?
How do you approach anti-seizure medication management when it was started by another team for a seizure-naive patient before/after craniotomy for a tumor?
When do you consider lumbar spinal fluid drainage after acute spinal cord injury?
At what point should surgical intervention be considered for vestibular schwannomas or other tumors in pediatric NF2 patients?
What do you consider when clearing prophylactic anticoagulation in a pediatric patient with metastases in a dural venous sinus?
Which tools do you use to prognosticate recovery after respiratory cardiac arrest in children, as in drowning?
What further workup do you recommend for isolated agenesis or dysgenesis of the corpus callosum?
Do you think that home INR monitoring is a feasible option for elderly, frail patients with atrial fibrillation on VKA treatment, given variations in socioeconomic status and access to care?
Which features should prompt vessel imaging in a pediatric patient with recurrent headaches?
